| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.2000.18.17.3108 |
| P698 | PubMed publication ID | 10963639 |
| P2093 | author name string | H Gadner | |
| A W Craft | |||
| S Ahrens | |||
| P A Voûte | |||
| M Paulussen | |||
| S J Cotterill | |||
| H F Jürgens | |||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 3108-3114 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group | |
| P478 | volume | 18 |
| Q84600159 | Q84600159 |
| Q41721716 | 18F-FDG PET/CT as an Indicator of Survival in Ewing Sarcoma of Bone |
| Q53169977 | 43 year old male with a right pelvic mass |
| Q33271991 | A Comparison Study of Staging Systems for Bone Sarcomas |
| Q33646555 | A Comparison of Pediatric vs. Adult Patients with the Ewing Sarcoma Family of Tumors |
| Q36700671 | A Decade in Banking Ewing Sarcoma: A Report from the Children's Oncology Group |
| Q47149930 | A Retrospective Multicentric Study of Ewing Sarcoma Family of Tumors in Patients Older Than 50: Management and Outcome. |
| Q36804676 | A case of small bowel metastasis from spinal Ewing sarcoma causing intussusception in an adult female |
| Q42105196 | A new method of lower extremity immobilization in radiotherapy |
| Q64251223 | A nomogram to predict prognosis in Ewing sarcoma of bone |
| Q102389005 | A novel HDGF-ALCAM axis promotes the metastasis of Ewing sarcoma via regulating the GTPases signaling pathway |
| Q36053369 | A peripheral primitive neuroectodermal tumor originating from the pancreas: a case report and review of the literature |
| Q36813562 | A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas. |
| Q36094955 | A pilot study of low‐dose anti‐angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893 |
| Q93334937 | A rapid review of evidence and recommendations from the SIOPE Radiation Oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID-19 pandemic or other crises |
| Q55265062 | A review of soft-tissue sarcomas: translation of biological advances into treatment measures. |
| Q35957623 | Adamantinoma-like Ewing family tumors of the head and neck: a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas |
| Q96587042 | Adamantinoma-like Ewing sarcoma of the thyroid |
| Q40458621 | Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin. |
| Q38784430 | Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma |
| Q42022322 | Adult ewing sarcoma: survival and local control outcomes in 102 patients with localized disease. |
| Q36508630 | Advances in paediatric cancer treatment |
| Q38217354 | Advances in therapy for pediatric sarcomas |
| Q38627336 | Advantages in Prognosis of Adult Patients with Ewing Sarcoma: 11-years Experiences and Current Treatment Management. |
| Q36174379 | Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children's Oncology Group Report. |
| Q37049291 | An Unusual Location of Extraosseous Ewing's Sarcoma |
| Q45948722 | Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. |
| Q36849432 | Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies |
| Q38022160 | Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience |
| Q54117193 | Apatinib for advanced sarcoma: results from multiple institutions' off-label use in China. |
| Q42533427 | Askin Rosai Tumour |
| Q34126509 | Askin's Tumor with Massive Hemoptysis |
| Q53650236 | Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors |
| Q80510573 | Biology and therapy of malignant solid tumors in childhood |
| Q36907188 | Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology Group. |
| Q37688646 | Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow |
| Q33274572 | Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up |
| Q36996436 | Can Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Be Used As a Useful Method to Evaluate the Treatment Response to Neoadjuvant Therapy Combined With Sorafenib and Anti-VEGF in Children Diagnosed With Metastatical Bone Sarcoma? |
| Q87157216 | Case 2: a 10-year-old girl with hip pain |
| Q55312953 | Case Study of a Young Adult With Ewing Sarcoma. |
| Q27853200 | Caspase-8 expression is predictive of tumour response to death receptor 5 agonist antibody in Ewing's sarcoma |
| Q84949075 | Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosis |
| Q47144320 | Characterization, survival analysis, and expression of IGFR in tumor samples from patients diagnosed with Ewing family tumors treated at the Barretos Cancer Hospital |
| Q34164686 | Chemotherapy in Ewing's sarcoma |
| Q37781925 | Chest Wall Ewing Sarcoma Family of Tumors: Long-Term Outcomes |
| Q27027664 | Children's Oncology Group's 2013 blueprint for research: bone tumors |
| Q35869242 | Clinical Activity of Pazopanib in Metastatic Extraosseous Ewing Sarcoma |
| Q39121566 | Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma |
| Q35848291 | Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement |
| Q35103701 | Clinical features and outcomes in patients with extraskeletal Ewing sarcoma |
| Q36368470 | Clinical features and outcomes in patients with secondary Ewing sarcoma |
| Q41587465 | Clinical features and outcomes of infants with Ewing sarcoma under 12 months of age. |
| Q43011472 | Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy |
| Q79611488 | Clinical outcome of patients with Ewing sarcoma family of tumors of bone in Japan: the Japanese Musculoskeletal Oncology Group cooperative study |
| Q37048919 | Clinical outcomes and prognostic factors of adult's Ewing sarcoma family of tumors: single center experience |
| Q46693659 | Clinicopathological Features and Treatment Outcomes in Ewing's Sarcoma Patients: A 10-year experience of Alexandria Clinical Oncology Department |
| Q34105623 | Comparative evaluation of strategies for quantifying signaling pathway proteins in Ewing sarcoma |
| Q34387256 | Comparison of Latino and non-Latino patients with Ewing sarcoma |
| Q40702959 | Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group |
| Q59812280 | Comparison of clinical features and outcomes in patients with extraskeletal vs skeletal Ewing sarcoma: an SEER database analysis of 3,178 cases |
| Q82847771 | Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience |
| Q38906382 | Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma |
| Q34373180 | Current Therapeutic Approaches in Metastatic and Recurrent Ewing Sarcoma |
| Q59809891 | Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct Diseases |
| Q30503995 | Cytotoxicity of activated natural killer cells against pediatric solid tumors |
| Q46538576 | Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors |
| Q40664507 | Delay in Diagnosis and Its Effect on Clinical Outcome in High-grade Sarcoma of Bone: A Referral Oncological Centre Study. |
| Q42782144 | Delayed Diagnosis of Metastatic Ewing Sarcoma Masked by Charcot-Marie-Tooth Disease |
| Q36803613 | Dendritic cell-Ewing's sarcoma cell hybrids enhance antitumor immunity |
| Q91069398 | Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group |
| Q38307074 | Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol |
| Q38088856 | Diagnosis and prognosis for the Ewing family of tumors. |
| Q34874355 | Differential disruption of EWS-FLI1 binding by DNA-binding agents |
| Q40759028 | Do Malignant Bone Tumors of the Foot Have a Different Biological Behavior than Sarcomas at Other Skeletal Sites? |
| Q41881517 | Dramatic response to Cisplatin window therapy in a boy with advanced metastatic ewing sarcoma |
| Q40142173 | EWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine model |
| Q42224745 | EWS/FLI-responsive GGAA microsatellites exhibit polymorphic differences between European and African populations. |
| Q92266003 | Easy-to-use clinical tool for survival estimation in Ewing sarcoma at diagnosis and after surgery |
| Q60309953 | Effectiveness of 18F-FDG PET/CT in the diagnosis, staging and recurrence monitoring of Ewing sarcoma family of tumors: A meta-analysis of 23 studies |
| Q37111796 | Emerging chemotherapeutic strategies and the role of treatment stratification in Ewing sarcoma |
| Q34652142 | Epidemiology and therapies for metastatic sarcoma |
| Q46023921 | Eribulin regresses a doxorubicin-resistant Ewing's sarcoma with a FUS-ERG fusion and CDKN2A-deletion in a patient-derived orthotopic xenograft (PDOX) nude mouse model. |
| Q91462563 | Establishment of a Nomogram-Based Model for Predicting the Prognostic Value of Inflammatory Biomarkers and Preoperative D-Dimer Level in Spinal Ewing's Sarcoma Family Tumors: A Retrospective Study of 83 Patients |
| Q33643417 | Ethnic and racial differences in patients with Ewing sarcoma |
| Q44062349 | Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography |
| Q51825432 | Evaluation of minimal disseminated disease in cryopreserved ovarian tissue from bone and soft tissue sarcoma patients |
| Q34463892 | Evaluation of plasma annexin V levels in children and young adults with solid tumors |
| Q64113037 | Ewing Sarcoma in Nepal Treated With Combined Chemotherapy and Definitive Radiotherapy |
| Q98894337 | Ewing Sarcoma of Fibula: A Pediatric Case of Disease Regression and Bone Regeneration. Case Report and Literature Review |
| Q40394642 | Ewing Sarcoma of the Head and Neck. |
| Q37980482 | Ewing Sarcoma: Clinical State-of-the-Art |
| Q34575191 | Ewing sarcoma of the bone in children under 6 years of age |
| Q35018615 | Ewing sarcoma of the liver with multilocular cystic mass formation: a case report |
| Q60933303 | Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years |
| Q36809238 | Ewing sarcoma of the thoracic epidural space in a young child |
| Q35719677 | Ewing sarcoma: the pediatrician's point of view |
| Q34481336 | Ewing tumour: incidence, prognosis and treatment options |
| Q33770830 | Ewing's Sarcoma Family Tumors in the Jaws: Case Report, Immunohistochemical Analysis and Literature Review |
| Q36169431 | Ewing's Sarcoma of the Zygomatic Arch Presenting in a 69-Year Old: An Unusual Case Report |
| Q30429655 | Ewing's family of tumors of the sinonasal tract and maxillary bone |
| Q81187571 | Ewing's sarcoma and primitive neuroectodermal tumor of hand and forearm. Experience of the Cooperative Ewing's Sarcoma Study Group |
| Q36244647 | Ewing's sarcoma family of tumors |
| Q50894700 | Ewing's sarcoma family of tumors in Finland during 1990-2009: a population-based study |
| Q53561818 | Ewing's sarcoma metastasis to the gastric wall in a 72-year-old patient. |
| Q87458538 | Ewing's sarcoma of bone |
| Q37897700 | Ewing's sarcoma of the masseter muscle |
| Q42050825 | Ewing's sarcoma of the ulna treated with sub-total resection and reconstruction using a non-vascularized, autogenous fibular graft and hernia mesh: A case report |
| Q37487126 | Ewing's sarcoma: overcoming the therapeutic plateau |
| Q37522056 | Ewing's sarcoma: standard and experimental treatment options |
| Q35548017 | Ewing’s Sarcoma Presenting as Pleural Effusion |
| Q91644156 | Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma |
| Q40695629 | Expression of nestin, CD133 and ABCG2 in relation to the clinical outcome in pediatric sarcomas. |
| Q92180651 | Extraskeletal Ewing Sarcoma: Report of an Extremely Rare Case in Temporal Region |
| Q44994788 | Extraskeletal Ewing sarcoma of the diaphragm presenting with hemothorax |
| Q50442629 | Extraskeletal Ewing's Sarcoma Presenting as a Mediastinal Mass |
| Q88575825 | Factors affecting survival outcomes of patients with non-metastatic Ewing's sarcoma family tumors in the spine: a retrospective analysis of 63 patients in a single center |
| Q89647103 | Feasibility of Treating Adults with Ewing or Ewing-Like Sarcoma with Interval-Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide |
| Q24185945 | Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) for detecting metastases of Ewing sarcoma |
| Q28283859 | G-Protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1 |
| Q38372566 | GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS). |
| Q92707400 | Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients |
| Q57197529 | Hernias and Ewing's sarcoma family of tumours: a pooled analysis and meta-analysis |
| Q45734249 | High burden of metastases and poor outcome in pelvic PNET |
| Q46987541 | High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital e |
| Q58760461 | High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008 |
| Q43082436 | High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk ewing sarcoma patients: a long-term follow-up single-center study. |
| Q44808020 | High-dose chemotherapy and autologous peripheral blood stem cell transfusion for adult and adolescent patients with small round cell sarcomas |
| Q43840272 | High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcoma |
| Q37845833 | High-dose chemotherapy and stem cell rescue for high-risk Ewing’s family of tumors |
| Q24187643 | High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with first recurrence of Ewing sarcoma |
| Q24187696 | High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with metastatic Ewing sarcoma |
| Q47564954 | High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors |
| Q37232948 | Identification of Discrete Prognostic Groups in Ewing Sarcoma |
| Q42542226 | Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group. |
| Q41005858 | Identifying prognostic indicators in staging metastatic sarcomas using hospital episode statistics |
| Q35760189 | Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma |
| Q36499007 | Imaging Pediatric Bone Sarcomas |
| Q34176966 | Imaging findings in craniofacial childhood rhabdomyosarcoma. |
| Q49993641 | Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT). |
| Q91611099 | Impact of chemotherapy cycles and intervals on outcomes of nonspinal Ewing sarcoma in adults: a real-world experience |
| Q27496197 | Improving Outcomes After Relapse in Ewing's Sarcoma: Analysis of 114 Patients From a Single Institution |
| Q36611954 | Incidence and prognostic value of tumour cells detected by RT-PCR in peripheral blood stem cell collections from patients with Ewing tumour |
| Q29353691 | Incidence, and gender, age and ethnic distribution of sarcomas in the republic of suriname from 1980 to 2008 |
| Q37499107 | Initial diagnostic management of pediatric bone tumors |
| Q44123967 | Intensive chemotherapy for children and young adults with metastatic primitive neuroectodermal tumors of the soft tissue |
| Q39181954 | Interactomic approach for evaluating nucleophosmin‐binding proteins as biomarkers for Ewing's sarcoma |
| Q73789167 | Intraoperative dural irradiation by customized 192iridium and 90yttrium brachytherapy plaques |
| Q58697750 | Introducing fluorescence guided surgery into orthopedic oncology: A systematic review of candidate protein targets for Ewing sarcoma |
| Q33559559 | Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children's Oncology Group |
| Q53082483 | Limited Margin Radiation Therapy for Children and Young Adults With Ewing Sarcoma Achieves High Rates of Local Tumor Control |
| Q37471137 | Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology Group. |
| Q84071685 | Local control of metastatic sites with radiation therapy in metastatic Ewing sarcoma and rhabdomyosarcoma |
| Q30738545 | Localised Ewing sarcoma/PNET of bone--prognostic factors and international data comparison |
| Q46260307 | Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone |
| Q92392992 | Loss of Stag2 cooperates with EWS-FLI1 to transform murine Mesenchymal stem cells |
| Q35225089 | Magnetic resonance imaging of sellar and juxtasellar abnormalities in the paediatric population: an imaging review |
| Q64954520 | Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion. |
| Q38678925 | Management and Outcome of Ewing Sarcoma of the Head and Neck. |
| Q28073218 | Management of Ewing sarcoma family of tumors: Current scenario and unmet need |
| Q37003304 | Membrane expression of MRP-1, but not MRP-1 splicing or Pgp expression, predicts survival in patients with ESFT |
| Q41601821 | Metastatic Ewing's Sarcoma: Revisiting the "Evidence on the Fence". |
| Q80387809 | Microsatellite instability in Ewing tumor is not associated with loss of mismatch repair protein expression |
| Q35957998 | Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours |
| Q40239182 | Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience |
| Q26740437 | Multimodality Treatment in Ewing's Sarcoma Family Tumors of the Maxilla and Maxillary Sinus: Review of the Literature |
| Q37392265 | Myeloablative therapy against high risk Ewing's sarcoma: A single institution experience and literature review |
| Q44222417 | Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic Institute. |
| Q77712154 | Non-metastatic Ewing's sarcoma of the ribs: the French Society of Pediatric Oncology Experience |
| Q41592288 | Nonmetastatic Ewing's Sarcoma of the Lumbar Spine in an Adult Patient |
| Q38113988 | Optimal Management of Ewing Sarcoma Family of Tumors: Recent Developments in Systemic Therapy |
| Q36988855 | Outcomes of 50 Patients With Ewing Sarcoma Family of Tumors Treated at a Single Institution in Taiwan |
| Q83983379 | Painful palatal swelling |
| Q39823354 | Pathobiologic Markers of the Ewing Sarcoma Family of Tumors: State of the Art and Prediction of Behaviour |
| Q44446307 | Pathological femoral fracture caused by primary bone tumour: a population-based study |
| Q41847093 | Pathology of Ewing's sarcoma/PNET: Current opinion and emerging concepts |
| Q36613417 | Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994. |
| Q52900259 | Pelvis Ewing sarcoma: Local control and survival in the modern era. |
| Q44128427 | Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas |
| Q33404428 | Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma. |
| Q36756669 | Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma |
| Q38212771 | Poly(ADP-ribose) polymerase inhibitors in Ewing sarcoma |
| Q34664539 | Pre-clinical and clinical significance of heparanase in Ewing's sarcoma. |
| Q61447009 | Precision medicine approaches for the management of Ewing sarcoma: current perspectives |
| Q46581978 | Prediction of response and prognostic factors for Ewing family of tumors in a low incidence population |
| Q36849620 | Primary Ewing Family of Tumors of the Jaw Has a Better Prognosis Compared to Tumors of Extragnathic Sites |
| Q50237399 | Primary Ewing sarcoma of the anterior mandible localized to the midline |
| Q94531373 | Primary Ewing sarcoma of the lung diagnosed on cytology: Case report with review of literature |
| Q92464303 | Primary Ewing's Sarcoma of Zygoma |
| Q37634905 | Primary Ewing's Sarcoma of the Sinonasal Tract: A Case Report |
| Q52952634 | Primary Ewing's sarcoma of the sinonasal tract in adults: A challenging disease. |
| Q38109298 | Primary Ewing’s sarcoma of the ethmoid sinus with intracranial and orbital extension: Case report and literature review |
| Q37958019 | Primary cutaneous Ewing sarcoma: a systematic review focused on treatment and outcome |
| Q33274167 | Primary malignant bone tumors—recent developments |
| Q50005991 | Primary orbital Ewing sarcoma family of tumors: a study of 12 cases |
| Q39660547 | Primary pediatric endobronchial Ewing sarcoma family of tumors |
| Q37222537 | Primary pulmonary Ewing's sarcoma/primitive neuroectodermal tumor in a 67-year-old man. |
| Q54315756 | Primary pulmonary Ewing's sarcoma: report of a case |
| Q42106838 | Primary soft tissue Ewing's sarcoma of the maxillary sinus in elderly patients: presentation, management and prognosis |
| Q37622882 | Primitive neuroectodermal tumor of the kidney in a child |
| Q45969231 | Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology. |
| Q35607070 | Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection |
| Q83831980 | Prognostic factors for overall survival in paediatric patients with Ewing sarcoma of bone treated according to multidisciplinary protocol |
| Q36644524 | Prognostic impact of chromosomal aberrations in Ewing tumours |
| Q37650605 | Prognostic role of tumor size in childhood cancer |
| Q36895474 | Prognostic significance of p16 INK4a alteration for Ewing sarcoma: a meta-analysis |
| Q41523153 | Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma |
| Q35832436 | Prognostic value of monocyte and neutrophils to lymphocytes ratio in patients with metastatic soft tissue sarcoma |
| Q37693473 | Proton radiotherapy for pediatric sarcoma |
| Q42542220 | Provider views on the management of Ewing sarcoma of the spine and pelvis |
| Q38333937 | Rapidly progressive primitive neuroectodermal tumor of the prostate: A case report and review of the literature |
| Q30315828 | Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease |
| Q35683306 | Reduced-Intensity Allogeneic Stem Cell Transplantation in Children and Young Adults with Ultrahigh-Risk Pediatric Sarcomas |
| Q40414026 | Referral patterns, treatment and outcome of high-grade malignant bone sarcoma in Scandinavia--SSG Central Register 25 years' experience |
| Q35887373 | Renal Primitive Neuroectodermal Tumor: Does Age at Diagnosis Impact Outcomes? |
| Q34989361 | Resection of pulmonary metastases in pediatric patients with Ewing sarcoma improves survival |
| Q38823482 | Results for patients with sarcoma not otherwise specified and other diagnoses than Ewing sarcoma treated according to the Euro-EWING 99 trial |
| Q93036058 | Risk factors for lung metastasis at presentation with malignant primary osseous neoplasms: a population-based study |
| Q90049793 | Risk factors for metastasis and poor prognosis of Ewing sarcoma: a population based study |
| Q90850814 | Risk stratification by somatic mutation burden in Ewing sarcoma |
| Q36187024 | Role of Radiotherapy in the Multimodal Treatment of Ewing Sarcoma Family Tumors |
| Q38184581 | Safety considerations for transplanting cryopreserved ovarian tissue to restore fertility in female patients who have recovered from Ewing's sarcoma |
| Q80510566 | Sarcoma |
| Q36711750 | Second cancers in patients with the Ewing sarcoma family of tumours |
| Q41094647 | Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy |
| Q37401172 | Sex-specific aspects of tumor therapy |
| Q35897904 | Should Aggressive Surgical Local Control Be Attempted in All Patients with Metastatic or Pelvic Ewing's Sarcoma? |
| Q35929870 | Significance of local treatment in patients with metastatic soft tissue sarcoma |
| Q88020702 | Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma |
| Q48239404 | Sinusoidal obstruction syndrome/veno-occlusive disease after high-dose intravenous busulfan/melphalan conditioning therapy in high-risk Ewing Sarcoma. |
| Q42398544 | Size matters for sarcomas! |
| Q39575598 | Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells |
| Q64226393 | Surgical Resection of Primary Ewing's Sarcoma of Bone Improves Overall Survival in Patients Presenting with Metastasis |
| Q91835865 | Surgical management of an adult manifestation of Ewing sarcoma of the spine-a case report |
| Q41908336 | Surgical management of pelvic Ewing's sarcoma |
| Q52611588 | Survival is influenced by approaches to local treatment of Ewing sarcoma within an international randomised controlled trial: analysis of EICESS-92. |
| Q87901855 | Survival of children treated for Ewing sarcoma in Lithuania: a single centre experience |
| Q34607877 | Synovial sarcoma: retrospective analysis of 250 patients treated at a single institution. |
| Q49787397 | T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-G. |
| Q37981129 | Targeted Therapy in Bone and Soft Tissue Sarcoma in Children and Adolescents |
| Q34262377 | Targeted Therapy of Ewing's Sarcoma |
| Q37624368 | Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody |
| Q35589492 | Targeted therapies for advanced Ewing sarcoma family of tumors |
| Q40033141 | Targeting death receptors: is this trail still hot? |
| Q36546372 | The Biology of Ewing Sarcoma |
| Q94497828 | The Clinical Heterogeneity of Round Cell Sarcomas with EWSR1/FUS Gene Fusions. Impact of Gene Fusion Type on Clinical Features and Outcome |
| Q60163325 | The Problem of Cancer in Children |
| Q38100720 | The Treatment Outcome for Adult Patients with Ewing’s Sarcoma |
| Q35957979 | The clinical use of biomarkers as prognostic factors in Ewing sarcoma |
| Q41865440 | The clone wars - revenge of the metastatic rogue state: the sarcoma paradigm. |
| Q84379718 | The diagnostic and prognostic value of ¹⁸F-FDG PET/CT in the initial assessment of high-grade bone and soft tissue sarcoma. A retrospective study of 89 patients |
| Q37114564 | The distinctive biology of cancer in adolescents and young adults. |
| Q51094795 | The effect of rotationplasty on the ankle joint: long-term results |
| Q60303321 | The efficacy and safety of apatinib in Ewing's sarcoma: a retrospective analysis in one institution |
| Q33626004 | The epidemiology of bone cancer in 0 - 39 year olds in northern England, 1981 - 2002 |
| Q90092850 | The impact of local control timing in Ewing sarcoma |
| Q34336937 | The impact of pathological fractures on therapy outcome in patients with primary malignant bone tumours |
| Q39541988 | The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma |
| Q64118178 | The relation of radiological tumor volume response to histological response and outcome in patients with localized Ewing Sarcoma |
| Q84928460 | The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES) |
| Q26768602 | Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting |
| Q41093026 | Three-year Follow up of GMCSF/bi-shRNA(furin) DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma |
| Q36486418 | Timing of Surgery and the Role of Adjuvant Radiotherapy in Ewing Sarcoma of the Chest Wall: A Single-institution Experience |
| Q40278945 | Topotecan and cyclophosphamide in adults with relapsed sarcoma. |
| Q39897087 | Total body MRI-governed involved compartment irradiation combined with high-dose chemotherapy and stem cell rescue improves long-term survival in Ewing tumor patients with multiple primary bone metastases |
| Q43185074 | Toxicity of high-dose chemotherapy with etoposide, thiotepa and CY in treating poor-prognosis Ewing's sarcoma family tumors: the experience of the Bambino Gesù Children's Hospital. |
| Q41817126 | Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity |
| Q64273200 | Treatment Outcomes of Pediatric Patients With Ewing Sarcoma in a War-Torn Nation: A Single-Institute Experience From Iraq |
| Q90712196 | Treatment and survival of osteosarcoma and Ewing sarcoma of the skull: a SEER database analysis |
| Q46084401 | Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group |
| Q33972685 | Treatment of nonmetastatic Ewing's sarcoma family tumors of the spine and sacrum: the experience from a single institution. |
| Q90351812 | Treatment of pelvic Ewing's sarcoma: Pros and cons of chemotherapy plus definitive radiotherapy versus surgery |
| Q40836328 | Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma |
| Q33835657 | Treatment pathway of bone sarcoma in children, adolescents, and young adults |
| Q37698012 | Tumours of the hand: a review on histology of bone malignancies |
| Q34496992 | UK Guidelines for the Management of Bone Sarcomas |
| Q26752425 | UK guidelines for the management of bone sarcomas |
| Q28242312 | Uncommon primary mediastinal tumours |
| Q35584126 | Understanding micrometastatic disease and Anoikis resistance in ewing family of tumors and osteosarcoma |
| Q26829949 | Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease Progression |
| Q35833419 | Whole Lung Irradiation in Adults with Metastatic Ewing Sarcoma: Practice Patterns and Implications for Treatment |
| Q49475956 | Whole-body magnetic resonance imaging for detection of skeletal metastases in children and young people with primary solid tumors - systematic review |
| Q34798483 | Why measure tumours? |
| Q46668388 | Zoledronic acid inhibits primary bone tumor growth in Ewing sarcoma |
| Q35115510 | Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing's sarcoma via inhibition of cell migration |
| Q79292305 | [Surgery of primary malignant bone tumors] |
Search more.